Literature DB >> 15339044

IGF-I receptor, cell-cell adhesion, tumour development and progression.

Loredana Mauro1, Eva Surmacz.   

Abstract

The insulin-like growth factor I receptor (IGF-IR) has been implicated in the development and progression of many common cancers and other neoplastic diseases. The tumorigenic potential of IGF-IR relies on its antiapoptotic and transforming activities. The molecular mechanisms by which IGF-IR controls the proliferation and survival of tumour cells have been extensively studied and many pathways have been delineated. However, the role of IGF-IR in the regulation of non-mitogenic cell functions is less well understood. Here we focus on IGF-IR-dependent cell-cell adhesion. Limited studies suggested that IGF-IR can regulate cell aggregation and intercellular adhesion mediated by cadherins and cadherin-associated proteins. We review the mechanisms of this process and discuss the impact of IGF-IR-dependent cell-cell adhesion on the phenotype of tumour cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339044     DOI: 10.1023/b:hijo.0000032356.98363.a2

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  99 in total

1.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

Review 2.  Cytoskeletal and adhesion proteins as tumor suppressors.

Authors:  A Ben-Ze'ev
Journal:  Curr Opin Cell Biol       Date:  1997-02       Impact factor: 8.382

3.  Expressed recombinant cadherins mediate cell sorting in model systems.

Authors:  A Nose; A Nagafuchi; M Takeichi
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

Review 4.  Oncogenes and the strategy of growth factors.

Authors:  R Baserga
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

Review 5.  The IGF axis and hepatocarcinogenesis.

Authors:  J G Scharf; F Dombrowski; G Ramadori
Journal:  Mol Pathol       Date:  2001-06

6.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

7.  E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.

Authors:  K F Becker; M J Atkinson; U Reich; I Becker; H Nekarda; J R Siewert; H Höfler
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

8.  The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells.

Authors:  M E Doerr; J I Jones
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

9.  Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.

Authors:  F K Guerra; A M Eijan; L Puricelli; D F Alonso; E Bal de Kier Joffé; A R Kornblihgtt; E H Charreau; P V Elizalde
Journal:  Int J Cancer       Date:  1996-03-15       Impact factor: 7.396

10.  Association of insulin receptor substrate-1 with integrins.

Authors:  K Vuori; E Ruoslahti
Journal:  Science       Date:  1994-12-02       Impact factor: 47.728

View more
  11 in total

1.  Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.

Authors:  V Bartella; P Rizza; I Barone; D Zito; F Giordano; C Giordano; S Catalano; L Mauro; D Sisci; M L Panno; S A W Fuqua; S Andò
Journal:  Breast Cancer Res Treat       Date:  2012-05-24       Impact factor: 4.872

2.  Intestine-specific transcription factor Cdx2 induces E-cadherin function by enhancing the trafficking of E-cadherin to the cell membrane.

Authors:  Shinsuke Funakoshi; Jianping Kong; Mary Ann Crissey; Long Dang; Duyen Dang; John P Lynch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-29       Impact factor: 4.052

3.  In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer.

Authors:  Stefania Catalano; Loredana Mauro; Daniela Bonofiglio; Michele Pellegrino; Hongyan Qi; Pietro Rizza; Donatella Vizza; Gianluca Bossi; Sebastiano Andò
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

4.  MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.

Authors:  Tianzhu Guo; Ying Feng; Qingyang Liu; Xue Yang; Tao Jiang; Yan Chen; Quangeng Zhang
Journal:  Tumour Biol       Date:  2014-08-13

5.  Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients.

Authors:  Hideo Suzuki; Juan C Roa; Toru Kawamoto; Kazunori Ishige; Ignacio I Wistuba; Donghui Li; Melanie B Thomas; Junichi Shoda
Journal:  Mol Clin Oncol       Date:  2015-02-25

6.  Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.

Authors:  P Kornprat; P Rehak; J Rüschoff; C Langner
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

Review 7.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

8.  IGF-IR in patients with advanced colorectal cancer in correlation with certain clinico-morphological factors: Initial report.

Authors:  Adam Kuklinski; Zbigniew Kamocki; Mariusz Koda; Zdzislaw Piotrowski; Stanislaw Sulkowski; Ryszard Lesniewicz; Krystyna Pawlak; Piotr Mysliwiec; Boguslaw Kedra
Journal:  Oncol Lett       Date:  2011-08-29       Impact factor: 2.967

9.  Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.

Authors:  Linda Yu; Katrin Saile; Carol D Swartz; Hong He; Xiaolin Zheng; Grace E Kissling; Xudong Di; Shantelle Lucas; Stanley J Robboy; Darlene Dixon
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

Review 10.  Cross-Talk between Adiponectin and IGF-IR in Breast Cancer.

Authors:  Loredana Mauro; Giuseppina Daniela Naimo; Emilia Ricchio; Maria Luisa Panno; Sebastiano Andò
Journal:  Front Oncol       Date:  2015-07-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.